Anti-angiotensin 2 receptor 1 antibody (anti-AT1R) and anti-endothelin receptor type a (anti-ETAR) as biomarkers of endothelial dysfunction in systemic sclerosis (SSc) patients

Authors

Institutions

Publication Details

Journal
Expert Review of Clinical Immunology
Published
2025-10-03
DOI
https://doi.org/10.1080/1744666x.2025.2574659
Primary Topic
Systemic Sclerosis and Related Diseases
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Anti-angiotensin 2 receptor 1 antibody (anti-AT1R) and anti-endothelin receptor type a (anti-ETAR) as biomarkers of endothelial dysfunction in systemic sclerosis (SSc) patients

Edoardo Rosato, Umberto Basile, Chiara Pellicano, Giancarlo D’Ippolito et al.
Expert Review of Clinical Immunology
Systemic Sclerosis and Related Diseases
article

Anti-angiotensin 2 receptor 1 antibody (anti-AT1R) and anti-endothelin receptor type a (anti-ETAR) as biomarkers of endothelial dysfunction in systemic sclerosis (SSc) patients

Edoardo Rosato, Umberto Basile, Chiara Pellicano, Giancarlo D’Ippolito, Valeria Carnazzo, Antonietta Gigante, Francesco Laterza, Gabriella Cusa, Annalisa Villa
article en

Abstract

No abstract available for this paper.
Expert Review of Clinical ImmunologyVol. 21(10)
Ospedale Santa Maria Goretti (IT), Sapienza University of Rome (IT)
Openalex Percentile: Top 60%
Systemic Sclerosis and Related Diseases
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.